Developer docs
API playgroundTry for free, no card

Search company profiles

Aktana

Full company profile

uuid0003bac

Namestring
Aktana
Legal namestring
Aktana, Inc.
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Aktana is a San Francisco-based AI platform company that delivers next-best-action decision support and omnichannel customer engagement solutions to life sciences organizations, including global pharmaceutical manufacturers, Medical Affairs groups, and MedTech companies. The platform is structured around three integrated product suites — Strategy Orchestration, Automated Intelligence, and Amplified Engagement — supported by enabling technologies such as the Contextual Intelligence Engine, the Omnichannel Data Interface for CRM interoperability, and a multi-agent Agentic AI architecture that provides explainable, auditable recommendations aligned with pharmaceutical regulatory requirements. Underlying the platform is the proprietary Knowledge Nexus dataset, built from 100M+ field suggestions and 5,000+ tactics executed over twelve years across 85+ validated use cases, which functions as the AI's long-term memory for life sciences commercial engagement patterns.

Aktana distributes its product via direct enterprise SaaS subscription to pharmaceutical brand teams, Medical Affairs units, and MedTech commercial groups, with deep integrations into Veeva CRM and Salesforce Marketing Cloud that embed recommendations inside daily field rep and brand manager workflows. The platform claims deployed outcomes including 36% NBRx lift, 19% sales performance increase, and 20 minutes saved per rep daily, and cites 350+ brands and 1,000+ deployments across customers including Novo Nordisk, Pfizer, Johnson & Johnson Innovative Medicine, Sanofi, Genentech, Abbott, Otsuka, Novartis, MSD, Axsome, and Dexcom. Gartner/analyst-side, Everest Group named Aktana a Leader and Star Performer in its 2024 Life Sciences Next-generation Customer Engagement Platforms PEAK Matrix assessment. On January 7, 2026, Aktana was acquired by PharmaForceIQ in an asset purchase transaction — terms undisclosed — combining Aktana's AI-driven field NBA capabilities with PharmaForceIQ's digital orchestration platform to deliver the first optichannel-in-a-box commercial engagement solution deployable in 6-8 weeks, with expanded reach into US, LATAM, APAC, and EMEA markets.

Short descriptiontext

Aktana is a San Francisco-based AI platform that delivers next-best-action recommendations and omnichannel customer engagement solutions to global pharmaceutical, Medical Affairs, and MedTech organizations, powered by a proprietary 12-year life sciences dataset.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI customer engagement, next-best-action platform, omnichannel orchestration, HCP engagement software, pharma commercial intelligence
Industry1 code
1Customer, Marketing & Sales Consulting
CodeBPAHACAGPrimaryYes
NAICS code3 codes
  • Marketing Consulting Services541613
  • Management Consulting Services54161
  • Software Publishers5132
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Prepackaged Software7372
Product category
Life Sciences Customer Engagement Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS/Platform Licensing
TypeSubscription Recurring
Description

Aktana operates as a SaaS platform providing AI-driven Next-Best-Action and omnichannel orchestration capabilities to life sciences companies on a subscription basis. The platform is sold as an integrated commercial engagement system deployable in 6–8 weeks.

aktana.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise SaaS platform for life sciences omnichannel orchestration
ModelSubscriptionBilling cadenceAnnual
Notes

No public pricing available. Quote-based sales motion targeting pharmaceutical and MedTech enterprises. Deployment cited as 6–8 weeks for integrated platform.

aktana.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Aktana builds and sells an AI-driven customer engagement platform for life sciences companies. The platform delivers Next-Best-Action recommendations, omnichannel orchestration, pre-call planning insights, and automated tactic optimization to pharmaceutical sales reps, brand managers, and Medical Affairs teams. It is sold on an annual subscription basis to pharmaceutical and MedTech enterprises and deployed via deep integrations with Veeva CRM and Salesforce Marketing Cloud, typically within 6–8 weeks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 15 values shown
  • 36% NBRx lift demonstrated across clients
+14 more records
Product overview1 text field

Aktana is an AI-powered customer engagement platform for life sciences companies, consisting of three integrated product suites (Strategy Orchestration, Automated Intelligence, and Amplified Engagement) built on the core Aktana Platform. The platform is powered by enabling technologies including the Contextual Intelligence Engine for real-time recommendations, the Omnichannel Data Interface for CRM interoperability, and Agentic AI for autonomous orchestration. The platform's core intelligence derives from the Optimizer & Orchestrator (Dynamically-Constrained Optimization Engine) and the proprietary Knowledge Nexus dataset (85+ use cases, 5,000+ tactics from 12+ years). The system integrates with Veeva CRM and Salesforce Marketing Cloud, serving 350+ brands with 1,000+ deployments across top global life sciences companies including Novo Nordisk, Pfizer, Johnson & Johnson, and Sanofi. The company was acquired by PharmaForceIQ in January 2026 to create the industry's first optichannel-in-a-box solution.

Product and service9 records
1Strategy Orchestration
CategoryProduct Suite
Description

Strategy Orchestration is a product suite that aligns brand strategy with field execution for seamless, omnichannel HCP engagement, enabling unified commercial customer engagement across field, digital, and peer-to-peer channels.

2Automated Intelligence
CategoryProduct Suite
Description

Automated Intelligence is a product suite that automates and scales personalized HCP engagement across omnichannel touchpoints through AI-driven insights and intelligent content curation for pharmaceutical commercial teams.

3Amplified Engagement
CategoryProduct Suite
Description

Amplified Engagement is a product suite that equips field sales teams with mobile-ready AI insights for real-time HCP engagement, pre-call planning, and actionable recommendations embedded inside their daily workflow and CRM.

4Aktana Platform
CategoryPlatform
Description

The Aktana Platform is the central AI engine for omnichannel coordination, integrating modular ML-powered capabilities with the Knowledge Nexus dataset and serving as the core intelligence layer sold as an enterprise SaaS subscription.

5Contextual Intelligence Engine
CategoryEnabling Technology
Description

The Contextual Intelligence Engine is a real-time AI engine that continuously synthesizes live HCP, field activity, and channel availability data to prioritize and deliver next-best actions across field and digital channels.

6Omnichannel Data Interface
CategoryEnabling Technology
Description

The Omnichannel Data Interface (ODI) supports seamless data migration and system interoperability during CRM transitions by harmonizing data across disparate sources (Veeva CRM, Salesforce Marketing Cloud) to keep intelligence investments accessible and actionable.

7Agentic AI
CategoryEnabling Technology
Description

Agentic AI is a multi-agent AI architecture enabling autonomous orchestration of omnichannel HCP engagement, with transparent and traceable decision-making aligned to life sciences regulatory requirements.

8Deployment & Managed Services
CategoryProfessional Services
Description

Deployment & Managed Services provide expert-led implementation and ongoing operational management of the Aktana Platform, ensuring seamless AI deployment and execution for life sciences customers.

9Business Transformation Consulting
CategoryConsulting Services
Description

Business Transformation Consulting provides AI-driven strategic consulting to help life sciences customers unlock commercial growth, redesign commercial processes, and operationalize the Aktana Platform across brand, commercial, and medical teams.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Deep product integration with Veeva CRM, including CRM Suggestions and pre-call planning insights delivered within Veeva workflows. Aktana V12 enhanced dismissal surveys within Veeva CRM and Veeva CRM MyInsights dashboards for district manager oversight. Integration announced alongside Veeva at multiple Commercial and Medical Summit events since 2015.

Strategic tierCoreTypeTechnology or Integration
Description

V14 release introduced seamless integration with Salesforce Marketing Cloud alongside continued Veeva CRM integration, expanding omnichannel execution capabilities across marketing automation platforms.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant CRM platform for life sciences with deep Veeva CRM, MyInsights, and Suggestions products. Veeva is both Aktana's deepest integration partner and its most credible potential competitor if it expands first-party NBA/AI features.

TypeBroad incumbent
Description

Global life sciences services and technology leader offering commercial analytics, AI-driven HCP engagement, and sales-force effectiveness tools that overlap directly with Aktana's Next-Best-Action and omnichannel orchestration offering.

TypeDirect peer
Description

Management consulting and technology firm selling AI-driven sales force effectiveness, Next-Best-Action, and omnichannel solutions to the same pharmaceutical commercial buyers Aktana serves; ZS's ZAIDYN platform is the closest direct competitor to Aktana's NBA stack.

TypeDirect peer
Description

Life sciences commercial analytics and AI software vendor with Axtria DataMax, SalesIQ, and MarketingIQ; competes head-to-head with Aktana for pharmaceutical commercial engagement and field decisioning budgets.

TypeDirect peer
Description

Healthcare commercialization services and AI/ML platform provider for pharma and MedTech; offers AI-driven HCP engagement, content, and next-best-action capabilities comparable to Aktana's product suites.

TypeBroad incumbent
Description

End-to-end life sciences commercialization services and technology provider with AI-driven field and patient engagement offerings overlapping with Aktana's brand and commercial solutions.

TypeDirect peer
Description

Specialized life sciences commercial consulting and advanced analytics firm delivering data-driven HCP targeting, segmentation, and field force optimization comparable to Aktana's Strategy Orchestration and Amplified Engagement suites.

TypeDirect peer
Description

Publicly traded pharma commercialization platform focused on physician engagement, AI-driven messaging, and point-of-care decisioning; competes for the same HCP engagement budget pool that Aktana addresses.

TypeBroad incumbent
Description

Cloud CRM and Marketing Cloud platforms used by pharma; offers AI features (Einstein) that increasingly overlap with Aktana's NBA and orchestration capabilities, especially given Aktana V14's Salesforce Marketing Cloud integration.

TypeEmerging player
Description

Digital orchestration platform for pharmaceutical commercial teams that acquired Aktana in January 2026 to form an optichannel-in-a-box solution; serves the same pharma brand and commercial buyers with overlapping omnichannel orchestration capabilities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aktana

Life Sciences Customer Engagement Softwareaktana.com

Aktana is a San Francisco-based AI platform that delivers next-best-action recommendations and omnichannel customer engagement solutions to global pharmaceutical, Medical Affairs, and MedTech organizations, powered by a proprietary 12-year life sciences dataset.

What Aktana does

Aktana is a San Francisco-based AI platform company that delivers next-best-action decision support and omnichannel customer engagement solutions to life sciences organizations, including global pharmaceutical manufacturers, Medical Affairs groups, and MedTech companies. The platform is structured around three integrated product suites — Strategy Orchestration, Automated Intelligence, and Amplified Engagement — supported by enabling technologies such as the Contextual Intelligence Engine, the Omnichannel Data Interface for CRM interoperability, and a multi-agent Agentic AI architecture that provides explainable, auditable recommendations aligned with pharmaceutical regulatory requirements. Underlying the platform is the proprietary Knowledge Nexus dataset, built from 100M+ field suggestions and 5,000+ tactics executed over twelve years across 85+ validated use cases, which functions as the AI's long-term memory for life sciences commercial engagement patterns.

Aktana distributes its product via direct enterprise SaaS subscription to pharmaceutical brand teams, Medical Affairs units, and MedTech commercial groups, with deep integrations into Veeva CRM and Salesforce Marketing Cloud that embed recommendations inside daily field rep and brand manager workflows. The platform claims deployed outcomes including 36% NBRx lift, 19% sales performance increase, and 20 minutes saved per rep daily, and cites 350+ brands and 1,000+ deployments across customers including Novo Nordisk, Pfizer, Johnson & Johnson Innovative Medicine, Sanofi, Genentech, Abbott, Otsuka, Novartis, MSD, Axsome, and Dexcom. Gartner/analyst-side, Everest Group named Aktana a Leader and Star Performer in its 2024 Life Sciences Next-generation Customer Engagement Platforms PEAK Matrix assessment. On January 7, 2026, Aktana was acquired by PharmaForceIQ in an asset purchase transaction — terms undisclosed — combining Aktana's AI-driven field NBA capabilities with PharmaForceIQ's digital orchestration platform to deliver the first optichannel-in-a-box commercial engagement solution deployable in 6-8 weeks, with expanded reach into US, LATAM, APAC, and EMEA markets.

Aktana firmographics

Firmographics
Name
Aktana
Legal name
Aktana, Inc.
Website
http://www.aktana.com
Company type
Private
Founded year
2008
Operating status
Acquired
Headcount range
101–250 employees
Short description
Aktana is a San Francisco-based AI platform that delivers next-best-action recommendations and omnichannel customer engagement solutions to global pharmaceutical, Medical Affairs, and MedTech organizations, powered by a proprietary 12-year life sciences dataset.
Ownership category
akta.pro rank

Aktana industry classification

Industry
Product category
Life Sciences Customer Engagement Software
NAICS
Marketing Consulting Services (541613), Management Consulting Services (54161), Software Publishers (5132)
SIC
Services-Management Consulting Services (8742), Services-Prepackaged Software (7372)
akta.pro primary industry
Customer, Marketing & Sales Consulting (BPAHACAG)

Keywords

  • AI customer engagement
  • Next-best-action platform
  • Omnichannel orchestration
  • HCP engagement software
  • Pharma commercial intelligence

Where Aktana is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Aktana business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. SaaS/Platform Licensing: Aktana operates as a SaaS platform providing AI-driven Next-Best-Action and omnichannel orchestration capabilities to life sciences companies on a subscription basis. The platform is sold as an integrated commercial engagement system deployable in 6–8 weeks.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS platform for life sciences omnichannel orchestration

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Aktana product offering

Product offering

Core offering

Aktana builds and sells an AI-driven customer engagement platform for life sciences companies. The platform delivers Next-Best-Action recommendations, omnichannel orchestration, pre-call planning insights, and automated tactic optimization to pharmaceutical sales reps, brand managers, and Medical Affairs teams. It is sold on an annual subscription basis to pharmaceutical and MedTech enterprises and deployed via deep integrations with Veeva CRM and Salesforce Marketing Cloud, typically within 6–8 weeks.

Product overview

Aktana is an AI-powered customer engagement platform for life sciences companies, consisting of three integrated product suites (Strategy Orchestration, Automated Intelligence, and Amplified Engagement) built on the core Aktana Platform. The platform is powered by enabling technologies including the Contextual Intelligence Engine for real-time recommendations, the Omnichannel Data Interface for CRM interoperability, and Agentic AI for autonomous orchestration. The platform's core intelligence derives from the Optimizer & Orchestrator (Dynamically-Constrained Optimization Engine) and the proprietary Knowledge Nexus dataset (85+ use cases, 5,000+ tactics from 12+ years). The system integrates with Veeva CRM and Salesforce Marketing Cloud, serving 350+ brands with 1,000+ deployments across top global life sciences companies including Novo Nordisk, Pfizer, Johnson & Johnson, and Sanofi. The company was acquired by PharmaForceIQ in January 2026 to create the industry's first optichannel-in-a-box solution.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategy Orchestration Strategy Orchestration is a product suite that aligns brand strategy with field execution for seamless, omnichannel HCP engagement, enabling unified commercial customer engagement across field, digital, and peer-to-peer channels.
  • Automated Intelligence Automated Intelligence is a product suite that automates and scales personalized HCP engagement across omnichannel touchpoints through AI-driven insights and intelligent content curation for pharmaceutical commercial teams.
  • Amplified Engagement Amplified Engagement is a product suite that equips field sales teams with mobile-ready AI insights for real-time HCP engagement, pre-call planning, and actionable recommendations embedded inside their daily workflow and CRM.
  • Aktana Platform The Aktana Platform is the central AI engine for omnichannel coordination, integrating modular ML-powered capabilities with the Knowledge Nexus dataset and serving as the core intelligence layer sold as an enterprise SaaS subscription.
  • Contextual Intelligence Engine The Contextual Intelligence Engine is a real-time AI engine that continuously synthesizes live HCP, field activity, and channel availability data to prioritize and deliver next-best actions across field and digital channels.
  • Omnichannel Data Interface The Omnichannel Data Interface (ODI) supports seamless data migration and system interoperability during CRM transitions by harmonizing data across disparate sources (Veeva CRM, Salesforce Marketing Cloud) to keep intelligence investments accessible and actionable.
  • Agentic AI Agentic AI is a multi-agent AI architecture enabling autonomous orchestration of omnichannel HCP engagement, with transparent and traceable decision-making aligned to life sciences regulatory requirements.
  • Deployment & Managed Services Deployment & Managed Services provide expert-led implementation and ongoing operational management of the Aktana Platform, ensuring seamless AI deployment and execution for life sciences customers.
  • Business Transformation Consulting Business Transformation Consulting provides AI-driven strategic consulting to help life sciences customers unlock commercial growth, redesign commercial processes, and operationalize the Aktana Platform across brand, commercial, and medical teams.

Quantifiable outcome

  • 36% NBRx lift demonstrated across clients
  • +14 more outcomes

Companies that use Aktana

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles2 records

Aktana technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability11 records

Feature7 records

Aktana partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • VeevacoreTechnology or IntegrationDeep product integration with Veeva CRM, including CRM Suggestions and pre-call planning insights delivered within Veeva workflows. Aktana V12 enhanced dismissal surveys within Veeva CRM and Veeva CRM MyInsights dashboards for district manager oversight. Integration announced alongside Veeva at multiple Commercial and Medical Summit events since 2015.
  • VeevacoreTechnology or IntegrationV14 release introduced seamless integration with Salesforce Marketing Cloud alongside continued Veeva CRM integration, expanding omnichannel execution capabilities across marketing automation platforms.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Aktana competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Dominant CRM platform for life sciences with deep Veeva CRM, MyInsights, and Suggestions products. Veeva is both Aktana's deepest integration partner and its most credible potential competitor if it expands first-party NBA/AI features.
  • IQVIA: Global life sciences services and technology leader offering commercial analytics, AI-driven HCP engagement, and sales-force effectiveness tools that overlap directly with Aktana's Next-Best-Action and omnichannel orchestration offering.
  • Eversana: End-to-end life sciences commercialization services and technology provider with AI-driven field and patient engagement offerings overlapping with Aktana's brand and commercial solutions.
  • Salesforce (Life Sciences Cloud / Marketing Cloud): Cloud CRM and Marketing Cloud platforms used by pharma; offers AI features (Einstein) that increasingly overlap with Aktana's NBA and orchestration capabilities, especially given Aktana V14's Salesforce Marketing Cloud integration.

Direct peers

  • ZS Associates: Management consulting and technology firm selling AI-driven sales force effectiveness, Next-Best-Action, and omnichannel solutions to the same pharmaceutical commercial buyers Aktana serves; ZS's ZAIDYN platform is the closest direct competitor to Aktana's NBA stack.
  • Axtria: Life sciences commercial analytics and AI software vendor with Axtria DataMax, SalesIQ, and MarketingIQ; competes head-to-head with Aktana for pharmaceutical commercial engagement and field decisioning budgets.
  • Indegene: Healthcare commercialization services and AI/ML platform provider for pharma and MedTech; offers AI-driven HCP engagement, content, and next-best-action capabilities comparable to Aktana's product suites.
  • Beghou Consulting: Specialized life sciences commercial consulting and advanced analytics firm delivering data-driven HCP targeting, segmentation, and field force optimization comparable to Aktana's Strategy Orchestration and Amplified Engagement suites.
  • OptimizeRx: Publicly traded pharma commercialization platform focused on physician engagement, AI-driven messaging, and point-of-care decisioning; competes for the same HCP engagement budget pool that Aktana addresses.

Emerging players

  • PharmaForceIQ: Digital orchestration platform for pharmaceutical commercial teams that acquired Aktana in January 2026 to form an optichannel-in-a-box solution; serves the same pharma brand and commercial buyers with overlapping omnichannel orchestration capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aktana social profiles

Digital presence

Aktana financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aktana leadership team

Management profile

Number of profiles

Profiles8 records

Aktana funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aktana M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aktana

What does Aktana do?

Aktana builds and sells an AI-driven customer engagement platform for life sciences companies. The platform delivers Next-Best-Action recommendations, omnichannel orchestration, pre-call planning insights, and automated tactic optimization to pharmaceutical sales reps, brand managers, and Medical Affairs teams. It is sold on an annual subscription basis to pharmaceutical and MedTech enterprises and deployed via deep integrations with Veeva CRM and Salesforce Marketing Cloud, typically within 6–8 weeks.

Is Aktana a public or private company?

Aktana is a private company. It is classified as corporate owned and is currently acquired.

When was Aktana founded?

Aktana was founded in 2008. It employs 101 to 250 people.

Where is Aktana based?

Aktana is headquartered in San Francisco, United States, in the North America region.

How does Aktana make money?

One revenue line is on record: saaS/Platform Licensing.

Who are Aktana's main competitors?

Broad incumbents on record are Veeva Systems, IQVIA, Eversana and Salesforce (Life Sciences Cloud / Marketing Cloud). Direct peers are ZS Associates, Axtria, Indegene, Beghou Consulting and OptimizeRx. PharmaForceIQ is listed as an emerging player.

Does Aktana have an API?

No public API is recorded for Aktana.

What industry is Aktana in?

Aktana's product category is Life Sciences Customer Engagement Software. Its primary akta.pro industry code is BPAHACAG, Customer, Marketing & Sales Consulting. Its NAICS code is 541613 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePharmaForceIQ Wins in PM360 Innovation AwardsPharmaForceIQ's Optichannel 360 platform won a PM360 Innovation Award 2026 in the Marketing Technology or Services Category. The AI-native platform coordinates pharmaceutical brand marketing and sales execution, deployed across over 100 brands. The company plans to bring hundreds more life sciences teams onto its answer-to-action platform.Pulse 2.0PharmaForceIQ Acquires Aktana To Combine Digital Orchestration With Field Next-Best-ActionPharmaForceIQ announced the acquisition of Aktana in an asset purchase that combines its digital orchestration platform with Aktana's AI-driven field Next-Best-Action capabilities to create what it calls the industry's first "optichannel-in-a-box" commercial engagement system for pharmaceutical companies. The combined offering is designed to unify brand and field strategy, improve executional alignment, and provide rapid measurement of commercial impact, with claimed outcomes including a 36% lift in new-to-brand prescriptions and a 19% sales performance increase following competitor launches. The transaction will deepen PharmaForceIQ's footprint in the United States while extending reach across Latin America, Asia-Pacific, and Europe, Middle East, and Africa markets.PR NewswirePharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for PharmaPharmaForceIQ announced its acquisition of Aktana, combining its digital orchestration platform with Aktana's AI-driven field Next-Best-Action platform to create an integrated commercial customer engagement solution for pharmaceutical companies. The strategic move establishes what the company claims is the industry's first optichannel-in-a-box solution that can be deployed in 6–8 weeks, integrating modular ML-powered capabilities with Aktana's proprietary Knowledge Nexus dataset built on 100M+ field suggestions and 5,000+ tactics executed over twelve years. The acquisition deepens PharmaForceIQ's footprint in the United States while expanding into LATAM, APAC, and EMEA markets, with Derek Choy, former Co-Founder and CPO of Aktana, now serving as PharmaForceIQ's Head of Product.PR NewswirePharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for PharmaPharmaForceIQ has announced its acquisition of Aktana, combining its digital orchestration platform with Aktana's AI-driven field Next-Best-Action platform. The acquisition creates the industry's first optichannel-in-a-box solution for pharma companies, offering an end-to-end commercial customer engagement system deployable in 6–8 weeks. The deal significantly expands PharmaForceIQ's footprint in the United States and extends its reach across LATAM, APAC, and EMEA regions.AktanaPharmaForceIQ Acquires Aktana to Deliver Impact for PharmaPharmaForceIQ announced the acquisition of Aktana on January 7, 2026, combining its digital orchestration platform with Aktana's AI-driven Next-Best-Action platform to create the industry's first optichannel-in-a-box solution for pharmaceutical companies. The integrated platform offers an end-to-end commercial customer engagement system deployable in 6–8 weeks, with demonstrated client outcomes including a 36% NBRx lift, 19% sales performance increase, and 20 minutes saved per sales rep daily. The acquisition expands PharmaForceIQ's footprint in the United States while extending its reach into LATAM, APAC, and EMEA regions.YahooPharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for PharmaPharmaForceIQ announced its acquisition of Aktana, combining its digital orchestration platform with Aktana's AI-driven field Next-Best-Action platform to create the pharmaceutical industry's first optichannel-in-a-box commercial customer engagement solution. The strategic move expands PharmaForceIQ's presence in the United States while extending its reach to LATAM, APAC, and EMEA regions, with demonstrated client impact including a 36% NBRx lift and 19% sales performance increase. The integrated platform aims to unify brand and field strategy, enabling pharma companies to deploy the end-to-end system in as little as 6–8 weeks.PharmaforceiqPharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for PharmaPharmaForceIQ announced its acquisition of Aktana, combining its digital orchestration platform with Aktana's AI-driven Next-Best-Action platform to create an end-to-end commercial customer engagement system for pharma companies. The deal forms the industry's first optichannel-in-a-box solution, deployable in 6-8 weeks, with demonstrated results including a 36% NBRx lift and 19% sales performance increase. The acquisition significantly expands PharmaForceIQ's footprint in the United States while extending its reach into LATAM, APAC, and EMEA regions.Deloitte United StatesEnd-to-end transformation of pharma's commercial activitiesA Deloitte report outlines the end-to-end digital transformation of pharmaceutical commercial activities, emphasizing the adoption of AI and data-driven CRM systems to shift from product-centric to customer-centric models. The article highlights specific operational successes, including a top-10 biopharma company achieving 14% higher sales through partnership with Aktana, and Sanofi implementing in-house AI solutions for yield optimization and inventory management.